312 related articles for article (PubMed ID: 19246456)
1. A highly conserved motif within the NH2-terminal coiled-coil domain of angiopoietin-like protein 4 confers its inhibitory effects on lipoprotein lipase by disrupting the enzyme dimerization.
Yau MH; Wang Y; Lam KS; Zhang J; Wu D; Xu A
J Biol Chem; 2009 May; 284(18):11942-52. PubMed ID: 19246456
[TBL] [Abstract][Full Text] [Related]
2. Identification of a new functional domain in angiopoietin-like 3 (ANGPTL3) and angiopoietin-like 4 (ANGPTL4) involved in binding and inhibition of lipoprotein lipase (LPL).
Lee EC; Desai U; Gololobov G; Hong S; Feng X; Yu XC; Gay J; Wilganowski N; Gao C; Du LL; Chen J; Hu Y; Zhao S; Kirkpatrick L; Schneider M; Zambrowicz BP; Landes G; Powell DR; Sonnenburg WK
J Biol Chem; 2009 May; 284(20):13735-13745. PubMed ID: 19318355
[TBL] [Abstract][Full Text] [Related]
3. The angiopoietin-like proteins ANGPTL3 and ANGPTL4 inhibit lipoprotein lipase activity through distinct mechanisms.
Shan L; Yu XC; Liu Z; Hu Y; Sturgis LT; Miranda ML; Liu Q
J Biol Chem; 2009 Jan; 284(3):1419-24. PubMed ID: 19028676
[TBL] [Abstract][Full Text] [Related]
4. GPIHBP1 stabilizes lipoprotein lipase and prevents its inhibition by angiopoietin-like 3 and angiopoietin-like 4.
Sonnenburg WK; Yu D; Lee EC; Xiong W; Gololobov G; Key B; Gay J; Wilganowski N; Hu Y; Zhao S; Schneider M; Ding ZM; Zambrowicz BP; Landes G; Powell DR; Desai U
J Lipid Res; 2009 Dec; 50(12):2421-9. PubMed ID: 19542565
[TBL] [Abstract][Full Text] [Related]
5. Fatty acids bind tightly to the N-terminal domain of angiopoietin-like protein 4 and modulate its interaction with lipoprotein lipase.
Robal T; Larsson M; Martin M; Olivecrona G; Lookene A
J Biol Chem; 2012 Aug; 287(35):29739-52. PubMed ID: 22773878
[TBL] [Abstract][Full Text] [Related]
6. Genetic variation in ANGPTL4 provides insights into protein processing and function.
Yin W; Romeo S; Chang S; Grishin NV; Hobbs HH; Cohen JC
J Biol Chem; 2009 May; 284(19):13213-22. PubMed ID: 19270337
[TBL] [Abstract][Full Text] [Related]
7. Angiopoietin-like 4 Modifies the Interactions between Lipoprotein Lipase and Its Endothelial Cell Transporter GPIHBP1.
Chi X; Shetty SK; Shows HW; Hjelmaas AJ; Malcolm EK; Davies BS
J Biol Chem; 2015 May; 290(19):11865-77. PubMed ID: 25809481
[TBL] [Abstract][Full Text] [Related]
8. Regulation of triglyceride metabolism by Angiopoietin-like proteins.
Mattijssen F; Kersten S
Biochim Biophys Acta; 2012 May; 1821(5):782-9. PubMed ID: 22063269
[TBL] [Abstract][Full Text] [Related]
9. Angiopoietin-like protein 3 inhibits lipoprotein lipase activity through enhancing its cleavage by proprotein convertases.
Liu J; Afroza H; Rader DJ; Jin W
J Biol Chem; 2010 Sep; 285(36):27561-70. PubMed ID: 20581395
[TBL] [Abstract][Full Text] [Related]
10. Angiopoietin-like protein 4 inhibition of lipoprotein lipase: evidence for reversible complex formation.
Lafferty MJ; Bradford KC; Erie DA; Neher SB
J Biol Chem; 2013 Oct; 288(40):28524-34. PubMed ID: 23960078
[TBL] [Abstract][Full Text] [Related]
11. On the mechanism of angiopoietin-like protein 8 for control of lipoprotein lipase activity.
Kovrov O; Kristensen KK; Larsson E; Ploug M; Olivecrona G
J Lipid Res; 2019 Apr; 60(4):783-793. PubMed ID: 30686789
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of lipoprotein lipase in 3T3-L1 adipocytes by angiopoietin-like protein 4 requires that both proteins have reached the cell surface.
Makoveichuk E; Vorrsjö E; Olivecrona T; Olivecrona G
Biochem Biophys Res Commun; 2013 Nov; 441(4):941-6. PubMed ID: 24220340
[TBL] [Abstract][Full Text] [Related]
13. Proteolytic processing of angiopoietin-like protein 4 by proprotein convertases modulates its inhibitory effects on lipoprotein lipase activity.
Lei X; Shi F; Basu D; Huq A; Routhier S; Day R; Jin W
J Biol Chem; 2011 May; 286(18):15747-56. PubMed ID: 21398697
[TBL] [Abstract][Full Text] [Related]
14. ANGPTL8 requires ANGPTL3 to inhibit lipoprotein lipase and plasma triglyceride clearance.
Haller JF; Mintah IJ; Shihanian LM; Stevis P; Buckler D; Alexa-Braun CA; Kleiner S; Banfi S; Cohen JC; Hobbs HH; Yancopoulos GD; Murphy AJ; Gusarova V; Gromada J
J Lipid Res; 2017 Jun; 58(6):1166-1173. PubMed ID: 28413163
[TBL] [Abstract][Full Text] [Related]
15. Comparison of angiopoietin-like protein 3 and 4 reveals structural and mechanistic similarities.
Gunn KH; Gutgsell AR; Xu Y; Johnson CV; Liu J; Neher SB
J Biol Chem; 2021; 296():100312. PubMed ID: 33482195
[TBL] [Abstract][Full Text] [Related]
16. Genetic Mimicry Analysis Reveals the Specific Lipases Targeted by the ANGPTL3-ANGPTL8 Complex and ANGPTL4.
Landfors F; Chorell E; Kersten S
J Lipid Res; 2023 Jan; 64(1):100313. PubMed ID: 36372100
[TBL] [Abstract][Full Text] [Related]
17. Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue.
Sukonina V; Lookene A; Olivecrona T; Olivecrona G
Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17450-5. PubMed ID: 17088546
[TBL] [Abstract][Full Text] [Related]
18. Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism.
Köster A; Chao YB; Mosior M; Ford A; Gonzalez-DeWhitt PA; Hale JE; Li D; Qiu Y; Fraser CC; Yang DD; Heuer JG; Jaskunas SR; Eacho P
Endocrinology; 2005 Nov; 146(11):4943-50. PubMed ID: 16081640
[TBL] [Abstract][Full Text] [Related]
19. Angiopoietin-like protein 4(E40K) and ANGPTL4/8 complex have reduced, temperature-dependent LPL-inhibitory activity compared to ANGPTL4.
Chen YQ; Pottanat TG; Siegel RW; Ehsani M; Qian YW; Roell WC; Konrad RJ
Biochem Biophys Res Commun; 2021 Jan; 534():498-503. PubMed ID: 33239171
[TBL] [Abstract][Full Text] [Related]
20. Mapping the sites of the lipoprotein lipase (LPL)-angiopoietin-like protein 4 (ANGPTL4) interaction provides mechanistic insight into LPL inhibition.
Gutgsell AR; Ghodge SV; Bowers AA; Neher SB
J Biol Chem; 2019 Feb; 294(8):2678-2689. PubMed ID: 30591589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
